Navigation Links
Top Monash researchers recognised with NHMRC Excellence Awards
Date:6/18/2014

Four of the NHMRC's 20 top prizes for excellence in health and medical research have been awarded to Monash researchers.

The National Health and Medical Research Council's Research Excellence Awards are presented to the top-ranked applicants across NHMRC's funding schemes.

Professor Jamie Rossjohn, Associate Professor Allen Cheng, Associate Professor Terry Haines and Dr Michael Roche all from the Faculty of Medicine, Nursing and Health Sciences, will accept their awards at the NHMRC's 200th Council Dinner this evening.

Federal Minister for Health Peter Dutton will present the awards, which highlight innovative and potentially transformative research.

NHMRC Australia Fellow Professor Rossjohn, who is to receive the Highest Ranked Project Grant, is a leading international expert on processes central to infection and immunity.

The grant will allow him to further investigate a type of T-cell, termed MAIT cell, that is found in abundance in the gastrointestinal system. The research may pave the way for the development of drugs that could either stimulate or suppress activity of this type of T-cell, potentially improving treatments for conditions such as tuberculosis and inflammatory bowel disease.

"My colleagues and I were delighted to receive NHMRC project grant funding to continue our work on MAIT cells and by the subsequent recognition by the NHMRC," Professor Jamie Rossjohn said.

Associate Professor Allen Cheng from the Department of Epidemiology and Preventive Medicine receives the Highest Ranked Career Development Fellowship Clinical, Level 2.

Based in the Department of Epidemiology & Preventative Medicine, Associate Professor Cheng is also Deputy Head of the Infection Prevention and Healthcare Epidemiology Unit at Alfred Health in Melbourne.

The Fellowship will enable Associate Professor Cheng to research ways to prevent and treat significant infections.

"I'm grateful to the NHMRC for their support in allowing me to combine research with my clinical work - I feel that it is important to provide evidence that supports clinical and public health practice. It's also great to work with colleagues at Alfred Health and Monash University who have been well represented amongst recipients of NHMRC Career Development Fellowships in recent years," Associate Professor Cheng said.

Associate Professor Terry Haines, Director of the Allied Health Research Unit at Monash Health and Director of Research for the Southern Physiotherapy, receives the Highest Ranked Career Development fellowship Population Health, Level 2.

A physiotherapist and health economist, Associate Professor Haines focuses on health services research across a range of health care settings.

"It is a great honour to be recognised by the NHMRC with this award. In saying this, I would recognise that my success would not be possible without the contributions of staff at Monash Health where I am based, and the many colleagues who I collaborate with locally, nationally, and internationally," Associate Professor Haines said.

The Fellowship will see Associate Professor Haines lead several projects including a trial introducing GPs as staff at aged-care facilities to reduce hospital admissions and improve resident care. He will also evaluate the benefits and cost effectiveness of weekend allied health services on acute medical and surgical wards.

The NHMRC Research Excellence Awards also include some special categories to acknowledge highly promising up and coming researchers in NHMRC's Project Grants scheme.

Dr Michael Roche from the Department of Infectious Diseases will be awarded the Frank Fenner Early Career Fellowship.

Focusing on the earliest steps of the HIV life cycle, Dr Roche's PhD looked at how the virus became resistant to a new antiviral drug, earning him the prestigious Mollie Holman Medal from the University.

"It's quite an honour to receive this award from the NHMRC," Dr Roche said.

He added that the award is also a credit to his PhD supervisor Professor Paul Gorry at the Burnet Institute and reflected the high standing of Professor Sharon Lewin's laboratory at the Department of Infectious Diseases.


'/>"/>

Contact: Lucy Handford
lucy.handford@monash.edu
Monash University
Source:Eurekalert

Related biology news :

1. No link found between soy food and endometrial cancer risk, say researchers
2. Researchers use virus to reveal nanopore physics
3. Researchers identify regulation process of protein linked to bipolar disorder
4. Researchers develop free online database for soybean studies
5. NYU and UCSF researchers develop a framework for monitoring oral cancer
6. LSTM researchers identify the complex mechanisms controlling changes in snake venom
7. CU researchers explain mechanism that helps viruses spread
8. UNC researchers pinpoint new role for enzyme in DNA repair, kidney cancer
9. EcoHealth 2014 connects researchers addressing impacts of global change on health and ecosystems
10. Iowa State, Ames Lab researchers find the mechanism that forms cell-to-cell catch bonds
11. Race could be a factor in head and neck cancer survival rates, MU researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology: